Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CDJ9292on Jun 16, 2017 10:04am
197 Views
Post# 26370468

RE:RE:RE:Financing not unexpected

RE:RE:RE:Financing not unexpected
sah1 wrote: Aureus, you are right to be critical. But nevertheless, the BLA has been filed. We know Pg will be approved. 4050 is looking to be a multi blockbuster drug. I hate this financing at $1.70. But it takes us another step closer. The future is there for all to see:-)


How can you honestly say "we know PG will be approved' ??? This is comical. More blatant pumping, time and time again. Funny how shorts get ridiculed on this board but pumpers are so wise and so smart......yet they've been wrong, consistently. 
Bullboard Posts